Jeff Yass’s Biostage, Inc. Common Stock BSTG Stock Holding History

Jeff Yass’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-13,387	Closed	-$4K	–	10413
2017 Q3	$4K	Buy	+13,387	New	+$5.36K	﹤0.01%	8712
2017 Q1	–	Sell	-47,879	Closed	-$43K	–	10699
2016 Q4	$43K	Buy	+47,879	New	+$42.7K	﹤0.01%	9325
2014 Q3	–	Sell	-11,386	Closed	-$119K	–	10311
2014 Q2	$119K	Buy	+11,386	New	+$97K	﹤0.01%	9361

Jeff Yass's BSTG Position: Q4 2017 in Review

Jeff Yass sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2017, closing a stake of 13,387 shares — an estimated $4K sold.

Jeff Yass first reported a position in BSTG in Q2 2014 and held it in 3 quarters. The position peaked at $119K in Q2 2014. 0 funds tracked by Wall St. Rank hold BSTG as of Q4 2017.

Jeff Yass reported no remaining Biostage, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Jeff Yass sold 13,387 Biostage, Inc. Common Stock shares in Q4 2017, an estimated $4K.
Jeff Yass first reported a position in Biostage, Inc. Common Stock in Q2 2014 and held it in 3 quarters.
Jeff Yass's Biostage, Inc. Common Stock position peaked at $119K in Q2 2014.
0 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2017.

Based on Susquehanna International Group's 13F filing for Q4 2017, filed 14 Feb 2018.